Shalini Arunogiri

Projects

Projects per year 2015 2020 2022 2029

• 1 Not started
• 7 Active
• 13 Finished

Projects per year

Search results

• Finished

  Acceptability and efficacy of app-based Resonant Breathing practice for reducing craving and alcohol consumption

  Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Catchlove, S. (Chief Investigator (CI)) & Roxburgh, A. (Chief Investigator (CI))

  Cooper Investors Pty Limited

  10/10/23 → 9/04/25

  Project: Research

• A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence

  Lintzeris, N. (Primary Chief Investigator (PCI)), Lubman, D. (Chief Investigator (CI)), Doyle, M. F. (Chief Investigator (CI)), Dunlop, A. J. (Chief Investigator (CI)), Mills, L. (Chief Investigator (CI)), Harrod, M. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Malouf, P. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Freeman, T. (Chief Investigator (CI)), Solowij, N. (Associate Investigator (AI)), Graham, R. (Associate Investigator (AI)), Childs, S. (Associate Investigator (AI)), Ella, S. (Associate Investigator (AI)), Montebello, M. (Associate Investigator (AI)), Nean, M. (Associate Investigator (AI)), Galettis, P. (Associate Investigator (AI)), Reeves, P. (Associate Investigator (AI)), Monds, L. A. (Associate Investigator (AI)) & Jefferies, M. (Associate Investigator (AI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/07/22 → 30/06/25

  Project: Research

• A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder

  Morley, K. C. (Primary Chief Investigator (PCI)), Haber, P. S. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Berk, M. (Chief Investigator (CI)), Baillie, A. (Chief Investigator (CI)), Connor, J. P. (Chief Investigator (CI)), Slade, T. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Clark, P. J. (Chief Investigator (CI)) & Arunogiri, S. (Chief Investigator (CI))

  1/07/21 → 30/06/25

  Project: Research

• A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine (“Ice”) dependence

  McKetin, R. (Primary Chief Investigator (PCI)), Arunogiri, S. (Chief Investigator (CI)), Farrell, M. P. (Chief Investigator (CI)), Degenhardt, L. (Chief Investigator (CI)), Dore, G. J. (Chief Investigator (CI)), Colledge, S. (Chief Investigator (CI)), Kelly, P. J. (Chief Investigator (CI)), Turner, A. (Chief Investigator (CI)) & Clare, P. J. (Chief Investigator (CI))

  1/06/21 → 31/05/25

  Project: Research

• A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder

  Manning, V. (Primary Chief Investigator (PCI)), Garfield, J. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Gavin, J. (Chief Investigator (CI)), Kotler, E. (Chief Investigator (CI)), George, S. (Chief Investigator (CI)), Okedara, G. (Chief Investigator (CI)) & Hopwood, M. (Chief Investigator (CI))

  National Centre for Clinical Research on Emerging Drugs

  24/01/20 → 31/03/22

  Project: Research

• Women's Voice @ Turning Point: A platform for meaningful consumer representation in addiction treatment for women at risk of homelessness

  Arunogiri, S. (Primary Chief Investigator (PCI))

  1/01/20 → 31/12/20

  Project: Research

• A randomised controlled trial of telephone-delivered psychological treatment to reduce methamphetamine use

  Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Grigg, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))

  1/01/20 → 31/12/23

  Project: Research

• Sex hormones, mood and alcohol use in women: towards a novel treatment target

  Arunogiri, S. (Primary Chief Investigator (PCI)), Gurvich, C. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)) & Lubman, D. (Chief Investigator (CI))

  Monash University – Internal Department Contribution

  23/09/19 → 30/09/20

  Project: Research

• Investigating the role of social cognition in hostility and violence in methamphetamine use and psychosis

  Arunogiri, S. (Primary Chief Investigator (PCI))

  Society for Mental Health Research Inc

  5/02/18 → 31/12/18

  Project: Research

• Development of the Methamphetamine Treatment Guidelines

  Grigg, J. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Volpe, I. (Chief Investigator (CI)), Frei, M. (Chief Investigator (CI)), Phan, V. (Chief Investigator (CI)), Rubenis, A. (Chief Investigator (CI)), Dias, S. (Chief Investigator (CI)), Petrie, M. (Chief Investigator (CI)), Sharkey, M. (Chief Investigator (CI)) & Lubman, D. (Chief Investigator (CI))

  1/06/17 → 30/06/18

  Project: Research

  File

• Development of evidence summary for a new treatment model for synthetic cannabinoid use problems

  Grigg, J. (Primary Chief Investigator (PCI)), Lubman, D. (Chief Investigator (CI)), Manning, V. (Chief Investigator (CI)) & Arunogiri, S. (Chief Investigator (CI))

  30/09/16 → 30/09/17

  Project: Research

  File

• Methamphetamine and psychosis: understanding risk factors

  Arunogiri, S. (Primary Chief Investigator (PCI))

  Windermere Foundation Ltd

  1/01/16 → 31/12/17

  Project: Research

• The investigation of markers of relapse and potential therapeutic targets in methamphetamine dependence using novel techniques

  Arunogiri, S. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/15 → 31/03/17

  Project: Research